DDrare: Database of Drug Development for Rare Diseases

145. ウエスト症候群
［臨床試験数：39，薬物数：50（DrugBank：13），標的遺伝子数：27，標的パスウェイ数：24］

Searched query = "West syndrome", "Infantile spasm"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = 18 FDG; ACTH; Acetate; Adrenocorticotropin hormone; CANNABIDIOL; CBD; Cannabidiol; Cannabidiol (CBD); Cannabidiol Oral Solution; Combination therapy with vigabatrin and prednisolone; Cosyntropin; Cosyntropin Injectable Suspension 1 MG/ML + vigabatrin; Cosyntropin Injectable Suspension, 1 mg/mL; Decortin H; Fenfluramine; GWP42003-P; Ganaxolone; Intravenous Methylprednisolone; JBPOS0101; M071754; Melatonin; Methylprednisolone; Modified Atkins diet; Null; Oral Pednisolone; Oral prednisolone; Other: modified Atkins diet; Prednisolone; Pyridoxine; Pyridoxine plus prednisolone; Radiprodil; SABRIL; SABRIL SACHETS; SOLUBLE PREDNISOLONE TABLETS; SPT3162; SYNACTHEN DEPOT; Sabril; Sabril granules for oral use; Sabrilex; Sabril®; Synacthen Depot; Tetracosactide; Tetracosactide Acetate; UCB3491; VGB-ST; VGB-ST soluble tablets; VIGABATRIN; Vigabatrin; Vigabatrin Tablets; Vigabatrin: Vigabatrin new ST formulation then Sabril®

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02092883 (ClinicalTrials.gov)	March 2013	14/3/2014	Evaluation of Neuroinflammation in Children With Infantile Spasms	Neuroinflammation in Children With Infantile Spasms Measured With 11C-PK11195 Positron Emission Tomography: Response to ACTH	Infantile Spasms	Drug: ACTH	Wayne State University	NULL	Completed	N/A	N/A	All	8	Phase 4	United States
2	NCT01367964 (ClinicalTrials.gov)	July 2011	3/6/2011	Prevention of West Syndrome With Low-dose Adrenocorticotropin Hormone (ACTH)	Early Treatment of Infants at High Risk of Developing West Syndrome With Low-dose Adrenocorticotropin Hormone (ACTH)	West Syndrome	Drug: adrenocorticotropin hormone	Ann & Robert H Lurie Children's Hospital of Chicago	Thrasher Research Fund	Unknown status	2 Months	12 Months	All	28	N/A	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT02092883
(ClinicalTrials.gov)

March 2013

14/3/2014

Evaluation of Neuroinflammation in Children With Infantile Spasms

Neuroinflammation in Children With Infantile Spasms Measured With 11C-PK11195 Positron Emission Tomography: Response to ACTH

Infantile Spasms

Drug: ACTH

Wayne State University

NULL

Completed

N/A

All

Phase 4

United States

NCT01367964
(ClinicalTrials.gov)

July 2011

3/6/2011

Prevention of West Syndrome With Low-dose Adrenocorticotropin Hormone (ACTH)

Early Treatment of Infants at High Risk of Developing West Syndrome With Low-dose Adrenocorticotropin Hormone (ACTH)

West Syndrome

Drug: adrenocorticotropin hormone

Ann & Robert H Lurie Children's Hospital of Chicago

Thrasher Research Fund

Unknown status

2 Months

12 Months

All

N/A

United States